Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_427fb20b081ea64a14728826b40dcc82 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6087 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-3156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2003-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a12d8e6861f6433a63285eabc3f1958 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0346b6882bc603f0867d2e02c9704acf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_212ba56a395897beda8a81a15f6b537b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_360fc82405d00b6f3a4ecc5e21a9c14f |
publicationDate |
2005-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20050086427-A |
titleOfInvention |
Compositions and methods for treating or preventing pneumococcal infection |
abstract |
The present invention relates to polypeptides, polysaccharide-polypeptide conjugates and expression vectors for the treatment and prevention of pneumococcal infections. The composition of the present invention induces an anti-pneumococcal immune response when administered to a mammal. The compositions of the present invention may be used as a prophylactic aspect of injecting a vaccine into a subject and / or as a therapeutic aspect inducing a therapeutic immune response in an infected subject. |
priorityDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |